Chest
-
Transplantation Case Report PosterSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Neosartorya pseudofisheri is widely found in the soil and acquired by aeroinhalation. It is a distinct species, but morphologically similar to Aspergillus fumigatus. Although an uncommon human pathogen, it is primarily encountered in immunocompromised hosts. ⋯ The following authors have nothing to disclose: Diana Kelm, Mark Wylam, Steve Peters, Mark Wilhelm, John Scott, Cassie KennedyNo Product/Research Disclosure Information.
-
Bronchology CasesSESSION TYPE: Case ReportsPRESENTED ON: Sunday, March 23, 2014 at 09:00 AM - 10:00 AMINTRODUCTION: Bacterial pseudomembranous tracheobronchitis is rare in the adult. There have been two cases reported from Japan showing tracheobronchitis due to Staphylococcus Aureus requiring tracheotomy and mechanical ventilation, one of them dying from complications. In immunocompromised patients, most cases reported have been secondary to aspergillus infection and have been associated with high mortality. We present an immunocompromised patient with bacterial pseudomembranous tracheobronchitis due to post-influenza S. Aureus infection. ⋯ Bronchoscopy with visualization of airway and lower respiratory samples is essential in the management of immunocompromised patients with respiratory symptoms particularly if disproportionate to imaging findings as it may imply airway involvement.Reference #1: Yamazaki Y, Hirai K, Honda T. Pseudomembranous tracheobronchitis caused by methicillin-resistant Staphylococcus Aureus. Scand J Infect Dis 2002; 34:211-213Reference #2: Namba Y, Mihara N, Tanaka M. [Fulminant tracheobronchitis caused by methicillin-resistant Staphylococcus. Nihon Kyobu Shikkan Gakkai Zasshi 1997; 35:969-973Reference #3: Fernandez-Ruiz M, Silva JT, San-Juan R, et al. Aspergillus tracheobronchitis: report of 8 cases and review of the literature. Medicine (Baltimore) 2012; 91:261-273DISCLOSURE: The following authors have nothing to disclose: Rafael Calderon Candelario, Karen Wood, Troy SchaffernockerNo Product/Research Disclosure Information.
-
Pulmonary Vascular Disease CasesSESSION TYPE: Case ReportsPRESENTED ON: Saturday, March 22, 2014 at 04:15 PM - 05:15 PMINTRODUCTION: Data has been published suggesting that iNO can be utilized in a variety of situations, however, there is little literature on its use in the setting of acute decompensation in valvular disease. ⋯ The following authors have nothing to disclose: Nicholas JuulNo Product/Research Disclosure Information.
-
Cancer CasesSESSION TYPE: Case ReportsPRESENTED ON: Sunday, March 23, 2014 at 09:00 AM - 10:00 AMINTRODUCTION: Paclitaxel is used to treat cancer of the ovaries, breast, and lung. Common side effects include hematologic, GI, and neuropathic. To date, there are only a handful of reported cases of pulmonary interstitial pneumonitis related specifically to Paclitaxel [1]. We report a case of Paclitaxel induced severe pulmonary interstitial pneumonitis responsive to steroid treatment. ⋯ The following authors have nothing to disclose: Anita Rajagopal, Niraj GuptaNo Product/Research Disclosure Information.
-
ILD PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Pulmonary complications of connective tissue disease (CTD) are common. Recent studies have shown benefit with rituximab (RTX) in the treatment of CTD related interstitial lung disease1,2. We performed a review to assess the benefit of RTX in five patients with pulmonary complications of CTD. ⋯ The following authors have nothing to disclose: Deirdre Fitzgerald, Sinead Harney, Michael HenryNo Product/Research Disclosure Information.